These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8584620)

  • 21. Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cells.
    Stephans SE; Miller GW; Levey AI; Greenamyre JT
    Neurotoxicology; 2002 Oct; 23(4-5):569-80. PubMed ID: 12428729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MPTP-induced ATP depletion and cell death in neuroblastoma X glioma hybrid NG 108-15 cells: protection by glucose and sensitization by tetraphenylborate.
    Kutty RK; Santostasi G; Horng J; Krishna G
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):377-88. PubMed ID: 1994518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies.
    Marongiu ME; Piccardi MP; Bernardi F; Corsini GU; Del Zompo M
    Neurosci Lett; 1988 Dec; 94(3):349-54. PubMed ID: 3264604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of a neurotoxic quaternary pyridinium metabolite in the liver of haloperidol-treated rats.
    Ablordeppey SY; Borne RF
    Pharmacol Biochem Behav; 1993 Nov; 46(3):739-44. PubMed ID: 8278454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells.
    Song X; Perkins S; Jortner BS; Ehrich M
    Neurotoxicology; 1997; 18(2):341-53. PubMed ID: 9291484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does ORP150/HSP12A protect dopaminergic neurons against MPTP/MPP(+)-induced neurotoxicity?
    Kitao Y; Matsuyama T; Takano K; Tabata Y; Yoshimoto T; Momoi T; Yamatodani A; Ogawa S; Hori O
    Antioxid Redox Signal; 2007 May; 9(5):589-95. PubMed ID: 17330988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite.
    Heikkila RE; Hwang J; Ofori S; Geller HM; Nicklas WJ
    J Neurochem; 1990 Mar; 54(3):743-50. PubMed ID: 2303810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia.
    Wright AM; Bempong J; Kirby ML; Barlow RL; Bloomquist JR
    Brain Res; 1998 Mar; 788(1-2):215-22. PubMed ID: 9555021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.
    Ransom BR; Kunis DM; Irwin I; Langston JW
    Neurosci Lett; 1987 Apr; 75(3):323-8. PubMed ID: 3495754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
    Storch A; Ott S; Hwang YI; Ortmann R; Hein A; Frenzel S; Matsubara K; Ohta S; Wolf HU; Schwarz J
    Biochem Pharmacol; 2002 Mar; 63(5):909-20. PubMed ID: 11911843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
    Michel PP; Dandapani BK; Sanchez-Ramos J; Efange S; Pressman BC; Hefti F
    J Pharmacol Exp Ther; 1989 Feb; 248(2):842-50. PubMed ID: 2783974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of an N-methyl-4-phenylpyridinium-like metabolite of the antidiarrheal agent loperamide in human liver microsomes: underlying reason(s) for the lack of neurotoxicity despite the bioactivation event.
    Kalgutkar AS; Nguyen HT
    Drug Metab Dispos; 2004 Sep; 32(9):943-52. PubMed ID: 15319335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium.
    Giovanni A; Sonsalla PK; Heikkila RE
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1008-14. PubMed ID: 7932148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
    Di Monte DA; Wu EY; Delanney LE; Irwin I; Langston JW
    J Pharmacol Exp Ther; 1992 Apr; 261(1):44-9. PubMed ID: 1560384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
    Wu WR; Zhu ZT; Zhu XZ
    Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
    Moy LY; Albers DS; Sonsalla PK
    Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxicity of MPTP and MPP+ in vitro: characterization using specific cell lines.
    Notter MF; Irwin I; Langston JW; Gash DM
    Brain Res; 1988 Jul; 456(2):254-62. PubMed ID: 3264740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of toxicity and cellular resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in adrenomedullary chromaffin cell cultures.
    Reinhard JF; Carmichael SW; Daniels AJ
    J Neurochem; 1990 Jul; 55(1):311-20. PubMed ID: 1972391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cells.
    Tasaki Y; Omura T; Yamada T; Ohkubo T; Suno M; Iida S; Sakaguchi T; Asari M; Shimizu K; Matsubara K
    Brain Res; 2010 Jul; 1344():25-33. PubMed ID: 20452332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.